CADL
Price
$5.45
Change
-$0.40 (-6.84%)
Updated
May 30 closing price
Capitalization
273.06M
93 days until earnings call
VSTM
Price
$7.50
Change
-$0.02 (-0.27%)
Updated
Jun 2, 10:45 AM (EDT)
Capitalization
413.22M
Interact to see
Advertisement

CADL vs VSTM

Header iconCADL vs VSTM Comparison
Open Charts CADL vs VSTMBanner chart's image
Candel Therapeutics
Price$5.45
Change-$0.40 (-6.84%)
Volume$1.1M
Capitalization273.06M
Verastem
Price$7.50
Change-$0.02 (-0.27%)
Volume$35.48K
Capitalization413.22M
CADL vs VSTM Comparison Chart
Loading...
CADL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CADL vs. VSTM commentary
Jun 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CADL is a Buy and VSTM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 02, 2025
Stock price -- (CADL: $5.45 vs. VSTM: $7.52)
Brand notoriety: CADL and VSTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CADL: 112% vs. VSTM: 96%
Market capitalization -- CADL: $273.06M vs. VSTM: $413.22M
CADL [@Biotechnology] is valued at $273.06M. VSTM’s [@Biotechnology] market capitalization is $413.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $307.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CADL’s FA Score shows that 0 FA rating(s) are green whileVSTM’s FA Score has 0 green FA rating(s).

  • CADL’s FA Score: 0 green, 5 red.
  • VSTM’s FA Score: 0 green, 5 red.
According to our system of comparison, VSTM is a better buy in the long-term than CADL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CADL’s TA Score shows that 4 TA indicator(s) are bullish while VSTM’s TA Score has 3 bullish TA indicator(s).

  • CADL’s TA Score: 4 bullish, 5 bearish.
  • VSTM’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CADL is a better buy in the short-term than VSTM.

Price Growth

CADL (@Biotechnology) experienced а +0.37% price change this week, while VSTM (@Biotechnology) price change was -9.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.39%. For the same industry, the average monthly price growth was +0.48%, and the average quarterly price growth was -5.03%.

Reported Earning Dates

CADL is expected to report earnings on Sep 03, 2025.

VSTM is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+1.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VSTM($413M) has a higher market cap than CADL($273M). VSTM YTD gains are higher at: 45.455 vs. CADL (-37.212). CADL has higher annual earnings (EBITDA): -48.83M vs. VSTM (-88.92M). VSTM has more cash in the bank: 113M vs. CADL (16.6M). CADL has less debt than VSTM: CADL (16M) vs VSTM (41.4M). VSTM has higher revenues than CADL: VSTM (10M) vs CADL (0).
CADLVSTMCADL / VSTM
Capitalization273M413M66%
EBITDA-48.83M-88.92M55%
Gain YTD-37.21245.455-82%
P/E RatioN/AN/A-
Revenue010M-
Total Cash16.6M113M15%
Total Debt16M41.4M39%
FUNDAMENTALS RATINGS
VSTM: Fundamental Ratings
VSTM
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CADLVSTM
RSI
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
85%
Momentum
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 6 days ago
85%
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 12 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
82%
Aroon
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CADL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LGLVX50.130.31
+0.62%
Lord Abbett Growth Leaders R6
ARYCX25.360.04
+0.16%
American Century Real Estate C
GNWRX30.540.04
+0.13%
Nationwide R
TADFX8.140.01
+0.12%
Transamerica Sustainable Equity Inc R6
NWAGX21.78-0.03
-0.14%
Nationwide Janus Henderson Overseas A

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with CYYNF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then CYYNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
-6.84%
CYYNF - CADL
46%
Loosely correlated
N/A
RPTX - CADL
41%
Loosely correlated
-0.72%
INO - CADL
33%
Loosely correlated
-6.10%
MDGL - CADL
33%
Poorly correlated
+1.97%
VSTM - CADL
32%
Poorly correlated
-3.22%
More

VSTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, VSTM has been loosely correlated with GNLX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if VSTM jumps, then GNLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VSTM
1D Price
Change %
VSTM100%
-3.22%
GNLX - VSTM
48%
Loosely correlated
-1.63%
ZLDAF - VSTM
47%
Loosely correlated
N/A
SNSE - VSTM
47%
Loosely correlated
-1.34%
HOOK - VSTM
40%
Loosely correlated
-1.24%
TGTX - VSTM
38%
Loosely correlated
-1.68%
More